Fingerprint
Dive into the research topics of 'Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically